Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 55.00 -0.22 (-0.40%) Streaming Delayed Price Updated: 12:04 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. ADR < Previous 1 2 ... 13 14 15 16 17 18 19 20 21 ... 29 30 Next > Daily Stock Analysis: Sanofi - November 2022 Snapshot November 16, 2022 Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company's decided in late 2019 to pull back from the cardio-metabolic... Via Talk Markets A Paradigm Shift In Healthcare Produces A Big Market Opportunity November 15, 2022 In a couple of years, Dario Heath could easily be a $100M+ company running 60%+ gross margins, be profitable and cash generating. Via Talk Markets Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads November 14, 2022 The fallout from a fake account continued Monday as Lilly reportedly pulled Twitter ads. Via Investor's Business Daily Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval? November 14, 2022 Learn More about Organicell Regenerative Medicine, Inc. by gaining access to the latest research report In the medical community, the popularity of regenerative medicine is reportedly soaring primarily... Via Benzinga Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion November 12, 2022 Insilico Medicine signed a six-drug research collaboration with Sanofi that could be worth up to $1.2 billion. Insilico will receive up to $21.5 million in upfront and target nomination fees for each... Via Talk Markets Sanofi (SNY) Q3 2022 Earnings Call Transcript October 28, 2022 SNY earnings call for the period ending September 30, 2022. Via The Motley Fool Sanofi Jumps As Strong Third-Quarter Profit Leads To Guidance Boost October 28, 2022 Sanofi stock jumped Friday after the company reported better-than-expected profit. Via Investor's Business Daily Dupixent, Flu Vaccine Demand Boost Sanofi's Q3 Earnings, Lifts Annual Outlook October 28, 2022 Via Benzinga 2 Top Biotech Stocks to Buy in November November 12, 2022 Both of these companies have potential catalysts on the way. Via The Motley Fool Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It November 11, 2022 A fake, but verified, Twitter account impersonated Eli Lilly and claimed insulin is free. Via Investor's Business Daily Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster November 10, 2022 Via Benzinga Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles November 10, 2022 Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen. Via Investor's Business Daily Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants November 04, 2022 Via Benzinga Why Is Provention Biosciences (PRVB) Stock Up 25% Today? November 03, 2022 Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab. Via InvestorPlace Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech October 04, 2022 Via Benzinga Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization From Next Year: Top Stories Tuesday, Nov. 01 November 01, 2022 Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production Via Benzinga Sanofi: Q3 Earnings Insights October 28, 2022 Sanofi (NASDAQ:SNY) reported its Q3 earnings results on Friday, October 28, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings Sanofi beat estimated earnings by... Via Benzinga Sanofi's Earnings Outlook October 27, 2022 Sanofi (NASDAQ:SNY) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that Sanofi will report an... Via Benzinga 3 Dividend Stocks That Could Soar 51% to 58%, According to Wall Street October 24, 2022 Two of these three pay especially attractive dividends. Via The Motley Fool US Stock Futures Lower Following Friday's Rally; Tesla In Focus October 24, 2022 Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording sharp gains in the previous session. The Dow Jones jumped by around 750 points on Friday. All the... Via Benzinga Earnings Scheduled For October 28, 2022 October 28, 2022 Companies Reporting Before The Bell • TAL Education (NYSE:TAL) is projected to report quarterly earnings at $0.01 per share on revenue of $242.62 million. Via Benzinga New Drugs Approvals Bring No Relief for Ailing Innovent Bio October 18, 2022 Key Takeaways: Innovent Bio has brought several drugs to market in recent years, including two announced last week, but is still losing money with no profits in sight The company has overhauled its... Via Benzinga 2 High-Yielding Dividend Stocks That Haven't Been This Cheap in Years October 14, 2022 Is now the time to buy Sanofi and Intel? Via The Motley Fool 3 Red-Hot Stocks That Could Continue to Beat the Market October 13, 2022 Investors are betting on these companies' revenue growth prospects. Via The Motley Fool Sanofi - Regeneron Tout Additional Positive Data From Flagship Dupixent Product October 11, 2022 Via Benzinga 2 Top Healthcare Stocks to Buy Right Now October 08, 2022 Healthcare is about as sticky of a business model as you'll find. Via The Motley Fool 7 Under-$50 Stocks to Buy to Tap Into a Hidden Bull Market October 07, 2022 Those seeking compelling market ideas during this storm may want to consider these relevant under-$50 stocks to buy. Via InvestorPlace 2 Stocks Jumping in Thursday's Premarket Trading October 06, 2022 Get an early start on the events of the day. Via The Motley Fool Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate October 06, 2022 Via Benzinga Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis September 29, 2022 Via Benzinga < Previous 1 2 ... 13 14 15 16 17 18 19 20 21 ... 29 30 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.